metoclopramide has been researched along with Experimental Mammary Neoplasms in 2 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Monte, O | 1 |
| Zyngier, S | 1 |
| Kimura, ET | 1 |
| Bianco, AC | 1 |
| Hirst, DG | 1 |
| Joiner, B | 1 |
| Hirst, VK | 1 |
2 other studies available for metoclopramide and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
[Dopaminergic and somatostatinergic pathways decrease serum thyrotropin in rats bearing the 256-Walker mammary carcinoma].
Topics: Animals; Carcinoma 256, Walker; Dopamine; Euthyroid Sick Syndromes; Hypothalamo-Hypophyseal System; | 2005 |
Blood flow modification by nicotinamide and metoclopramide in mouse tumours growing in different sites.
Topics: Animals; Cardiac Output; Colonic Neoplasms; Male; Mammary Neoplasms, Experimental; Metoclopramide; M | 1993 |